CS logo
small CS logo
Orszagos Onkologiai Intezet

Budapest, Hungary
Hospital in Budapest
Budapest, Ráth György u. 7-9, 1122

About Orszagos Onkologiai Intezet


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
15
European Organisation for Research and Treatment of Cancer - EORTC
13
Pfizer
12
ETOP IBCSG Partners Foundation
10
National Institute of Oncology, Hungary
7
Incyte Corporation
6
Eli Lilly and Company
4
Gilead Sciences
4
Bayer
3
Institut de Recherches Internationales Servier
3
AVEO Pharmaceuticals, Inc.
2
Total Rows: 75

Clinical Trials at Orszagos Onkologiai Intezet


During the past decade, Orszagos Onkologiai Intezet conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 42 clinical trials were completed, i.e. on average, 48.8% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 19 clinical trials were completed. i.e. 54.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years888813131313991010131312124422664477558844Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer
1993-05-01
2010-08-01
Completed
473
Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
1996-03-01
Completed
320
Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
1998-01-01
Completed
780
Combination Chemotherapy in Treating Men With Germ Cell Cancer
1998-10-01
Unknown status
498
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
1999-04-01
2015-03-01
Completed
359
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
2000-12-01
2008-10-01
Completed
Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium
2001-01-01
Completed
238

Rows per page:

1–100 of 155

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Orszagos Onkologiai Intezet" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 13 trials sponsored, "Pfizer" with 12 trials sponsored, "ETOP IBCSG Partners Foundation" with 10 trials sponsored and "National Institute of Oncology, Hungary" with 10 trials sponsored. Other sponsors include 93 different institutions and companies that sponsored additional 75 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Orszagos Onkologiai Intezet" #1 collaborator was "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "Breast International Group" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator and "ADIR, a Servier Group company" with 3 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 54 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 15Hoffmann-La Roche: 15European Organisationfor Research andTreatment of Cancer -EORTC: 13European Organisationfor Research andTreatment of Cancer -EORTC: 13Pfizer: 12Pfizer: 12ETOP IBCSG PartnersFoundation: 10ETOP IBCSG PartnersFoundation: 10National Institute ofOncology, Hungary: 7National Institute ofOncology, Hungary: 7Incyte Corporation: 6Incyte Corporation: 6Eli Lilly and Company: 4Eli Lilly and Company: 4Gilead Sciences: 4Gilead Sciences: 4Bayer: 3Bayer: 3Institut de RecherchesInternationales Servier:3Institut de RecherchesInternationales Servier:3

Created with Highcharts 11.1.0Top CollaboratorsMerck Sharp & Dohme LLC: 5Merck Sharp & Dohme LLC: 5Breast International Group: 4Breast International Group: 4NCIC Clinical Trials Group: 4NCIC Clinical Trials Group: 4National Cancer Institute (NCI): 4National Cancer Institute (NCI): 4ADIR, a Servier Groupcompany: 3ADIR, a Servier Groupcompany: 3AbbVie: 3AbbVie: 3AstraZeneca: 3AstraZeneca: 3ETOP IBCSG PartnersFoundation: 3ETOP IBCSG PartnersFoundation: 3Astellas Pharma Inc: 2Astellas Pharma Inc: 2Australasian Leukaemiaand Lymphoma Group:2Australasian Leukaemiaand Lymphoma Group:2

Clinical Trials Conditions at Orszagos Onkologiai Intezet


According to Clinical.Site data, the most researched conditions in "Orszagos Onkologiai Intezet" are "Breast Cancer" (21 trials), "Colorectal Cancer" (6 trials), "Breast Neoplasms" (4 trials), "Chronic Lymphocytic Leukemia" (4 trials) and "Melanoma" (4 trials). Many other conditions were trialed in "Orszagos Onkologiai Intezet" in a lesser frequency.

Clinical Trials Intervention Types at Orszagos Onkologiai Intezet


Most popular intervention types in "Orszagos Onkologiai Intezet" are "Drug" (139 trials), "Biological" (18 trials), "Procedure" (14 trials), "Radiation" (7 trials) and "Device" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "Gemcitabine" (10 trials), "Rituximab" (10 trials), "Docetaxel" (8 trials) and "Paclitaxel" (8 trials). Other intervention names were less common.

Clinical Trials Genders at Orszagos Onkologiai Intezet


The vast majority of trials in "Orszagos Onkologiai Intezet" are 116 trials for "All" genders, 29 trials for "Female" genders and 10 trials for "Male" genders.

Clinical Trials Status at Orszagos Onkologiai Intezet


Currently, there are NaN active trials in "Orszagos Onkologiai Intezet". undefined are not yet recruiting, 31 are recruiting, 29 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 70 completed trials in Orszagos Onkologiai Intezet, undefined suspended trials, and 18 terminated clinical trials to date.
Out of the total trials that were conducted in Orszagos Onkologiai Intezet, 15 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 101 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 101Phase 3: 101Phase 2: 40Phase 2: 40Phase 1: 15Phase 1: 15Not Applicable: 6Not Applicable: 6Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 70Completed: 70Recruiting: 31Recruiting: 31Active, not recruiting: 29Active, not recruiting: 29Terminated: 18Terminated: 18Unknown status: 5Unknown status: 5Available: 1Available: 1Enrolling by invitation: 1Enrolling by invitation: 1

Departments of Orszagos Onkologiai Intezet


Orszagos Onkologiai Intezet has several departments that took part in Clinical trials: "Orszagos Onkologiai Intezet "B" Belgyogyaszati osztaly" - 22 trials, "Országos Onkológiai Intézet, C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály" - 8 trials, "Orszagos Onkologiai Intezet - Nogyogyaszati Osztaly" - 4 trials, "Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly" - 4 trials, "Orszagos Onkologiai Intezet Sugarterapias Osztaly" - 3 trials, "Orszagos Onkologiai Intezet, Gyogyszertar" - 2 trials